Chinese
Home
About Livzon
Milestones
Leaders' Caring
Company Honors
Cultural Vision
Contact Us
Media
Livzon News
Employment system
Investor Relations
Company Governance
Announcement
Financial Reports
ESG Report
Shareholder Returns
Stock Information
Sustainable Development
Human Development
Board Diversity Policy
Business Ethics
Supplier
Environment, Occupational Health and Safety (EHS)
Philanthropy
Privacy Policy
Tax policy
ESG Ratings and Honors
Product
Leading Products
Products List
ADR Reporting
R&D
R&D Platforms
Livzon microspheres
Livzon Bio
Livzon Research Institute
R&D Achievements
IP Achievements
Overseas Market
Overseas Business
Specialty Products
Certificates
Contact us
Join Us
Social Recruitment
Campus Recruitment
Compensation and Benefits
Appeal Against
Bidding procurement
Tender Announcement
Supplier Login
Supervision and Reporting
Contact information
Online message
ESG report
Shareholder returns
Stock information
Contacts
2026
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
(1) CANCELLATION OF CERTAIN SHARE OPTIONS AND (2) FIRST EXERCISE PERIOD UNDER THE FIRST GRANT MEETS THE EXERCISE CONDITIONS
File size:
184.8KB
File Type:
pdf
2023-12-18
PROXY FORM FOR THE 2024 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, 12 JANUARY 2024
193.4KB
NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING
203.0KB
PROPOSED SPIN-OFF AND LISTING OF LIVZON DIAGNOSTICS ON NATIONAL EQUITIES EXCHANGE AND QUOTATIONS
199.6KB
INSIDE INFORMATION INCLUSION OF THE COMPANY'S PRODUCTS IN THE MEDICAL INSURANCE CATALOGUE
225.4KB
2023-12-13
INSIDE INFORMATION PROPOSED SPIN-OFF AND LISTING OF LIVZON DIAGNOSTICS ON NATIONAL EQUITIES EXCHANGE AND QUOTATIONS
159.7KB
2023-12-10
Next Day Disclosure Return
88.3KB
2023-12-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
64.5KB
2023-12-04
VOLUNTARY ANNOUNCEMENT THE INCLUSION OF RECOMBINANT SARS-COV-2 BIVALENT (ORIGINAL/OMICRON XBB) FUSION PROTEIN VACCINE (CHO CELL)
145.0KB
2023-12-03
COMPLETION OF REGISTRATION OF THE RESERVED GRANT OF THE 2022 SHARE OPTIONS INCENTIVE SCHEME
104.9KB
2023-11-29
